TVM Capital Life Science has invested $25 million in Lamab Biologics Inc., which is taking forward a new twist on an old story in tackling allergic conditions. The asset-centric virtual company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback